Fig. 3From: Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world studyPercentages of children achieving seizure freedom during the last 12-month period stratified by number of baseline ASMs (the total number of people in each group was 70, 32, and 3 patients; the number of seizure-free to lacosamide in each group was 34, 15, and 1 patients)Back to article page